• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.03% Nasdaq Up1.29%

    Onconova Therapeutics, Inc. (ONTX)

    -NasdaqGS
    2.28 Down 0.04(1.72%) May 1, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 114   114   125   447  
    Cost of Revenue -   -   -   -  
    Gross Profit 114   114   125   447  
    Operating Expenses
    Research Development10,387  11,886  12,904  14,248  
    Selling General and Administrative3,086  3,116  3,985  4,932  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (13,359) (14,888) (16,764) (18,733)
    Income from Continuing Operations
    Total Other Income/Expenses Net(12)(19)(16)17  
    Earnings Before Interest And Taxes(13,371)(14,907)(16,780)(18,716)
    Interest Expense2   -   -   -  
    Income Before Tax(13,373)(14,907)(16,780)(18,716)
    Income Tax Expense19   -   -   -  
    Minority Interest20  29  27  37  
    Net Income From Continuing Ops(13,372)(14,878)(16,753)(18,679)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (13,372) (14,878) (16,753) (18,679)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (13,372) (14,878) (16,753) (18,679)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.